PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#ANDA078670 ×

UPDATED
Regulatory Updates
Aug 30, 2026•1 min read
FDA Approves ANDA078670 for Pioglitazone Hydrochloride Tablets
FDA has approved ANDA078670 submitted by Aiping Pharm Inc for prescription pioglitazone hydrochloride tablets in 15 mg, 30 mg, and 45 mg strengths.